In this op-ed, Jeff Scheir makes his case against using ozone in cultivating cannabis.
The FDA is paying close attention to companies marketing CBD products with unapproved drug claims for both human use and animal use.
Just My Type: Using Archetypes in Branding
Make sure your branding shines by having your product stand out on the shelf.
A hotshot young German cannabis start-up re-organizes in the aftermath of a summer of scandals and missteps.
Political influence and money from Canadian cannabis is clearly in the room regarding Brexit issues. How much this benefits patients is another story.
Does an aggressive two-year timeframe for recreational reform in the heart of Europe mean the rest of the region will follow suit?
A study of one of Biotech Institute’s earliest utility patents on the cannabis plant.
After changing ownership without notifying the state, Massachusetts slapped a $250,000 fine on Curaleaf, adding to the company’s misfortune.
The many problems of Canadian companies have come home to roost – with insiders hinting of industry-wide implications.
